Sarcoma Foundation of Announces 2017 Research Grants
DAMASCUS, Md. – May 24, 2017 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased awareness and research for sarcoma, today announced that it has awarded $500,000 in research funds to deserving scientists at institutions across the United States as part of its 2017 SFA Research Grant program. Ten research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a rare cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best, most promising research toward the cure for sarcoma.
Since its inception, the SFA has invested more than $7 million in sarcoma research through its national grant program and collaborative research projects, including a recent PD-1 Clinical Trial. More information on SFA’s research program can be found at www.curesarcoma.org/research/.
Sarcoma Foundation of America 2017 Research Grants
Dr. Richard and Valerie Aronsohn Memorial Research Award
Matthew Cascio, DO
University of Florida
“CART Cells for Sarcoma”
Dr. Richard and Valerie Aronsohn Memorial Research Award
Erin Dickerson, PhD
University of Minnesota – Twin Cities
“Targeting the sarcoma tumor microenvironment using adrenergic receptor antagonists”
Pittsburgh Cure Sarcoma Research Award
Cheryl London, DVM, PhD
Tufts Medical Center
“Interrogating the regulation, function and therapeutic potential of monocarboxylate transporters in osteosarcoma”
Race to Cure Sarcoma Research Award
David Kirsch, MD, PhD
Duke University
“Dissecting Mechanisms of Immune Mediated Radiation Resistance in Sarcomas”
STL Cure Sarcoma Research Award
Anette Duensing, MD
University of Pittsburgh
“Targeting the retinoid acid pathway: a new therapeutic strategy for IDH1/2-mutant chondrosarcomas”
STL Cure Sarcoma Research Award
Fumito Ito, MD, PhD
Roswell Park Cancer Institute
“Pluripotent Stem Cell-derived Genome-edited Sarcoma-targeted T cells for Immunotherapy”
Sarcoma Foundation of America Research Award
Timothy Bowler, MBBCh, PhD
Memorial Sloan Kettering Cancer Center
“Towards precision immunotherapy for undifferentiated pleomorphic sarcoma (UPS)”
Sarcoma Foundation of America Research Award
David Largaespada, PhD
University of Minnesota – Twin Cities
“Identifying chemoresistance pathways in Osteosarcoma”
Sarcoma Foundation of America Research Award
Anang Shelat, PhD
St. Jude Children’s Research Hospital
“Rational biomarker-guided PARP inhibitor combination therapy in pediatric sarcomas”
Sarcoma Foundation of America Research Award
Brian Van Tine, MD, PhD
Washington University in St. Louis
“Targeting the alterations of Lipid Metabolism in ASS1 Deficient Sarcomas to Induce Synthetic Lethality”
About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit www.curesarcoma.org.
About Sarcoma
Sarcoma is a rare cancer in adults (1 percent of all adult cancers) but rather prevalent in children (about 20 percent of all childhood cancers). At any one time, 50,000 patients and their families are struggling with sarcoma. Every year, nearly 15,000 new cases are diagnosed and about 6,000 people die from the disease.
###
Contact Information
Lori Hoffman
(301) 253-8687